Ultravist and Asphyxia - a phase IV clinical study of FDA data

Summary:

Asphyxia is reported as a side effect among people who take Ultravist (iopromide), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Acetylcysteine, and have Computerised tomogram abdomen.

The phase IV clinical study analyzes which people have Asphyxia when taking Ultravist. It is created by eHealthMe based on reports of 9,241 people who have side effects when taking Ultravist from the FDA, and is updated regularly.

What is Ultravist?

Ultravist has active ingredients of iopromide. eHealthMe is studying from 9,246 Ultravist users. Check the latest studies of Ultravist.

What is Asphyxia?

Asphyxia (a condition in which there is an extreme decrease in the concentration of oxygen in the body) is found to be associated with 556 drugs and 821 conditions by eHealthMe. Check the latest studies of Asphyxia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

9,241 people reported to have side effects when taking Ultravist.
Among them, 40 people (0.43%) have Asphyxia.

Among these 40 people:

How long have people been on Ultravist when they have Asphyxia? *

What is the gender of people who have Asphyxia when taking Ultravist? *

female: 50 %
male: 50 %

What is the age of people who have Asphyxia when taking Ultravist? *

What are other drugs people take besides Ultravist? *

What are other side effects people have besides Asphyxia? *

Rashes (redness): 11 people, 27.50%
Urticaria (rash of round, red welts on the skin that itch intensely): 6 people, 15.00%
Dyspnea (difficult or laboured breathing): 6 people, 15.00%
Cough: 5 people, 12.50%
Nausea (feeling of having an urge to vomit): 5 people, 12.50%
Nausea And Vomiting: 5 people, 12.50%
Hypotension (abnormally low blood pressure): 5 people, 12.50%
High Blood Pressure: 4 people, 10.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 7.50%
Cardiac Arrest: 3 people, 7.50%

What are the existing conditions these people have? *

Computerised Tomogram Abdomen: 8 people, 20.00%
Urinary Tract Infection: 2 people, 5.00%
Percutaneous Coronary Intervention: 2 people, 5.00%
Pneumonia: 1 person, 2.50%
Pain: 1 person, 2.50%

* Approximation only. Some reports may have incomplete information.

Do you take Ultravist and have Asphyxia?

- Check whether Asphyxia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ultravist:

Ultravist (9,246 reports)

Asphyxia treatments and more:

Asphyxia (9,188 reports)

Browse all side effects of Ultravist:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Asphyxia:

Asphyxia (556 drugs)

Browse all the conditions that are associated with Asphyxia:

Asphyxia (821 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on iopromide (the active ingredients of Ultravist) and Ultravist (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.